4.42 USD
▼-1.24-6.95%
盘后 5.11 +7.58%
2026-08-03
市值
$2.13M
市盈率
—
EPS
-141.83
股息率
—
52 周区间
4.65 – 1,210.00
成交量
409.08K
Beta
-0.89
目标价
—
52W 低 4.6552W 高 1,210.00
价格走势
公司简介
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company’s technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company’s lead product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is bei...